IP Library Granted Patent US 11,060,124
Granted Patent B2
US 11,060,124 · App. 15/969,616 · Granted Jul 13, 2021

Methods for making high intensity sweeteners

Inventors: Andrew P. Patron (San Marcos, CA); Chris Edano Noriega (San Diego, CA); Rama R. Manam (San Diego, CA); Justin Colquitt (San Diego, CA); Nathan Faber (San Diego, CA); Helge Zieler (Del Mar, CA); Justin Stege (San Diego, CA)
Assignee: Firmenich Incorporated
C12P33/00A23L27/36C07J17/005C12N9/0042C12N9/244C12N9/90C12P33/12C12P33/20C12Y106/02004C12Y302/01006C12Y504/99003A23V2002/00C12P19/18C12P19/56
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,060,124
App. No.
15/969,616
Granted
Jul 13, 2021
Kind
B2
Abstract

Provided herein include methods of making mogroside compounds, e.g., Compound 1, compositions (for example host cells) for making the mogroside compounds, and the mogroside compounds made by the methods disclosed herein, and compositions (for example, cell lysates) and recombinant cells comprising the mogroside compounds (e.g., Compound 1). Also provided herein are novel cucurbitadienol synthases and the use thereof.

Claims (5)

1. A method of producing Compound 1 having the structure of:

the method comprising:

contacting mogroside III E with an enzyme capable of catalyzing a reaction for the production of the compound 1 from the mogroside III E , wherein the enzyme comprises an amino acid sequence having at least 90% sequence identity to any one of the sequences set forth in SEQ ID NOs: 2, and 103 having dextransucrase activity or wherein the enzyme having dextransucrase activity is encoded by a gene comprising a nucleic acid sequence having at least 90% sequence identity to any one of SEQ ID NOs:104, and 105.

2. The method of claim 1 , the mogroside III E is contacted with a recombinant host cell that comprises the gene comprising the nucleic acid sequence having at least 90% sequence identity to any one of SEQ ID NOs: 104, and 105 encoding the enzyme having dextransucrase activity.

3. The method of claim 2 , wherein the mogroside III E is present in and/or produced by the recombinant host cell.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Apr 2, 2021
From: SENOMYX, INC.; FIRMENICH INCORPORATED
To: FIRMENICH INCORPORATED
Reel/Frame 055807/0644 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2018
From: PATRON, ANDREW P.; NORIEGA, CHRIS EDANO; MANAM, RAMA R.; COLQUITT, JUSTIN; FABER, NATHAN; ZIELER, HELGE; STEGE, JUSTIN
To: SENOMYX, INC.
Reel/Frame 045933/0397 →
Continuity (3)
Provisional Application 62551750 · Aug 29, 2017
Provisional Application 62501018 · May 3, 2017
Related Publication 20190071705A1 · Mar 7, 2019
Cited By (5)
US 12,234,464 US 12,247,238 US 12,286,661 US 12,338,476 US 12,480,146